2025年欧盟国家癌症概况综合报告（英）

Investment Rating - The report does not explicitly provide an investment rating for the industry Core Insights - The report highlights the growing public health concern of cancer in the EU, driven by an ageing population and decreasing cancer mortality rates, although disparities remain among lower-income countries and demographics [17][18] - Improvements in cancer risk factors have been noted, particularly in smoking rates, but challenges persist with rising obesity rates [19] - Early detection efforts are facing declines in screening participation, despite some advancements in colorectal cancer screening [20] - Enhanced cancer survival rates are leading to increased focus on rehabilitation and quality of life programs for cancer survivors [21] Summary by Sections 1. Cancer Burden - The ageing population and lower cancer mortality rates are contributing to an increase in the number of people living with cancer, with an estimated 2,742,447 new cancer cases expected in the EU in 2022 [33][34] - Cancer incidence is higher among men (684 per 100,000) compared to women (488 per 100,000), with significant variations across EU countries [33][39] 2. Risk Factors and Prevention Policies - Tobacco smoking has decreased in almost all EU countries, with an average reduction from 22% in 2012 to 18% in 2022 [74] - Alcohol consumption has seen a slight decrease, averaging 10.0 liters per person aged 15 and over in 2022, with significant country-level variations [78] - Overweight and obesity remain significant challenges, with over half of adults in the EU classified as overweight [72] 3. Early Detection - Participation in breast cancer screening has declined in over half of EU countries, while cervical cancer screening has decreased in two-thirds of countries [20] - Many countries have introduced population-based colorectal cancer screening, promoting earlier detection [20] 4. Cancer Care Performance - There are ongoing efforts to improve accessibility and quality of cancer care, with notable improvements in survival estimates across EU countries [32][35] - The increasing cancer burden is impacting health systems and economies, necessitating investments in follow-up and rehabilitative care [35][37] 5. Spotlight on Paediatric Cancer Care - Over 50% of new cancer diagnoses among children are from three main types: leukaemia, brain cancer, and non-Hodgkin's lymphoma [40] 6. Cancer Performance Trackers - The report includes a Cancer Performance Tracker (CaPTr) for each country, assessing performance across various cancer domains [22]